|EPIFLO® has FDA clearance to provide safe and effective Transdermal Continuous Oxygen Therapy [TCOT] for the treatment of:
- Skin ulcerations due to diabetes, venous stasis, post-surgical infections and gangrenous lesions Decubitus Ulcers (bedsores, pressure sores)
- Amputations and infected stumps
- Skin grafts
How it Works
The air you breathe contains 21% oxygen. EPIFLO® extracts oxygen from the air, concentrates it to near 100%, and “pumps” the oxygen through the cannula to blanket the wound. The wound is covered with a fully occlusive dressing of the doctors choice. The dressing does not inflate and the patient has no sensation of air movement. EPIFLO® provides a silent, continuous, slow flow of oxygen (3 ml/hr for 15 days) that will not dry out the wound. Some clinicians suggest that EPIFLO® mimics the bloodstream in delivering the necessary metabolic energy to oxygen starved cells. EPIFLO® energizes ischemic cells to jump start the natural healing process. Oxygen helps form collagen, granulation tissue, new blood vessels and skin.
Easy to Use: No special storage conditions – minimal training; simple on / off switch; attaches to patient in less than 30 seconds
Safe: Non-implantable – non-ingestible – no use of tanks, chambers or oxygen storage.
Continuous Treatment: Uninterrupted continuous delivery of oxygen 24 hours per day for up to 15 days.
Convenient: No daily trips to the hospital to receive oxygen treatment – dressing changes as needed to maintain good wound care.
Effective: May be used for a broad list of chronic wounds. Efficacy proven on the most recalcitrant, non-healing or slow healing chronic wounds. (See Instructions for Use below).
Instructions for Use
See the EPIFLO® Instructions for Use page or the instructions accompanied with the product for details on how to apply